Market Overview:
The global hepatitis C virus (HCV) antiviral market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of HCV, rising demand for better treatment options, and technological advancements in HCV diagnostics and therapeutics. The HCV antibody segment is expected to account for the largest share of the global hepatitis C virus (HCV) antiviral market in 2018. This segment is anticipated to grow at a CAGR of 7.8% from 2018 to 2030 due to increasing awareness about HCV and its diagnosis among healthcare professionals and patients worldwide. The viral load testing segment is projected to grow at the highest rate during the forecast period owingto growing demand for early diagnosis and treatment of HCV infection.
 Antiviral Industry Outlook.svg)
Product Definition:
Hepatitis C virus (HCV) antiviral is a drug that is used to treat hepatitis C. It is important because hepatitis C can cause serious damage to the liver and can be fatal. The antiviral drugs work by blocking the ability of the virus to reproduce, which helps to reduce the amount of virus in the body and may help improve liver function.
HCV Antibody:
HCV antibody is used for the detection of antibodies in the blood or serum. It is also used for detecting HCV infection in patients' samples. The presence of anti-HCV antibody does not guarantee that a person has been infected with HCV; however, it provides useful information about a patient's health and risk factors associated with hepatitis C virus infection.
HCV Viral Load:
HCV viral load is the total number of HCV particles in a sample. It can be estimated by various methods, which include the use of monoclonal antibodies, flow cytometry, and serology tests. The most commonly used method for quantification is flow cytometry using Fluorescence- labeled Antibody (FlAb) technique because it provides accurate results and has been standardized across laboratories.
Application Insights:
Based on the application, the global hepatitis C virus (HCV) antiviral market is segmented into diagnostic centers, hospitals and home use. The diagnostic centers held the largest share in 2017 owing to increasing prevalence of chronic hepatitis C and growing demand for sensitive HCV tests. According to WHO, an estimated 90% of patients with chronic hepatitis B & C are found among low-income countries. Thus, a large patient base requiring diagnosis is expected to fuel growth during forecast period.
The hospital segment is anticipated to witness lucrative growth over the forecast period due largely to government initiatives that encourage early diagnosis.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of HCV infected population, high adoption rate for new treatment methods, and increasing awareness about early diagnosis. In addition, favorable reimbursement policies are also aiding in market growth. For instance, as per an article published by NCBI; as of 2016 almost 80%of all HCV treatments were covered by insurance (either public or private).
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to factors such as improving healthcare infrastructure and rising prevalence of chronic diseases coupled with growing disposable income & consumer awareness about newly introduced therapies among others.
Growth Factors:
- Increasing incidence of HCV infection: The global incidence of HCV infection is increasing due to various factors such as the increasing number of people who are at risk for contracting the virus and the lack of effective preventive measures. This is expected to drive demand for antiviral drugs used to treat HCV infections.
- Growing awareness about available treatments: There is growing awareness among patients and healthcare professionals about the availability of effective treatments for HCV infections. This is likely to lead to an increase in demand for these drugs in the coming years.
- Launch of new, innovative therapies: Pharmaceutical companies are investing heavily in research and development efforts aimed at developing new, innovative therapies for HCV infections. This is likely to result in an increase in competition among manufacturers, which will benefit patients by driving down prices and improving access to treatment options.
- Expanding patient population: The patient population eligible for treatment with currently available antiviral drugs continues to expand as more countries adopt guidelines recommending earlier treatment initiation across all risk groups including those with mild or no liver fibrosis (scarring). This trend is expected to contribute significantly towards growth of the antiviral market over the forecast period . 5)Growing focus on public health initiatives: Governments around the world are increasingly focusing on public health initiatives aimed at preventing and controlling outbreaks of infectious diseases such as hepatitis C virus infection..This is expectedto have a positive impact on growth prospectsfortheantiviralmarketovertheforecast
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis C Virus (HCV) Antiviral Market Research Report
By Type
HCV Antibody, HCV Viral Load, HCV Genotyping
By Application
Diagnostic Centers, Hospitals, Home Use
By Companies
Roche Diagnostics, Abbott, Siemens, Qiagen, bioMérieux, Bio-Rad Laboratories, Meridian Bioscience, Vista Diagnostics, Biogate Laboratories, J.Mitra & Co. Ltd, Siemens Medical, General Biologicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis C Virus (HCV) Antiviral Market Report Segments:
The global Hepatitis C Virus (HCV) Antiviral market is segmented on the basis of:
Types
HCV Antibody, HCV Viral Load, HCV Genotyping
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers, Hospitals, Home Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abbott
- Siemens
- Qiagen
- bioMérieux
- Bio-Rad Laboratories
- Meridian Bioscience
- Vista Diagnostics
- Biogate Laboratories
- J.Mitra & Co. Ltd
- Siemens Medical
- General Biologicals
 Antiviral Market Overview.svg)
Highlights of The Hepatitis C Virus (HCV) Antiviral Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HCV Antibody
- HCV Viral Load
- HCV Genotyping
- By Application:
- Diagnostic Centers
- Hospitals
- Home Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis C Virus (HCV) Antiviral Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Antiviral Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HCV antiviral therapy is a treatment for HCV that aims to stop the virus from replicating and causing disease. This can be done through different methods, including medications, surgery, or a combination of both.
Some of the key players operating in the hepatitis c virus (hcv) antiviral market are Roche Diagnostics, Abbott, Siemens, Qiagen, bioM©rieux, Bio-Rad Laboratories, Meridian Bioscience, Vista Diagnostics, Biogate Laboratories, J.Mitra & Co. Ltd, Siemens Medical, General Biologicals.
The hepatitis c virus (hcv) antiviral market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hepatitis C Virus (HCV) Antiviral Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hepatitis C Virus (HCV) Antiviral Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hepatitis C Virus (HCV) Antiviral Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hepatitis C Virus (HCV) Antiviral Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hepatitis C Virus (HCV) Antiviral Market Size & Forecast, 2020-2028
4.5.1 Hepatitis C Virus (HCV) Antiviral Market Size and Y-o-Y Growth
4.5.2 Hepatitis C Virus (HCV) Antiviral Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 HCV Antibody
5.2.2 HCV Viral Load
5.2.3 HCV Genotyping
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostic Centers
6.2.2 Hospitals
6.2.3 Home Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hepatitis C Virus (HCV) Antiviral Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hepatitis C Virus (HCV) Antiviral Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 HCV Antibody
9.6.2 HCV Viral Load
9.6.3 HCV Genotyping
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostic Centers
9.10.2 Hospitals
9.10.3 Home Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 HCV Antibody
10.6.2 HCV Viral Load
10.6.3 HCV Genotyping
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostic Centers
10.10.2 Hospitals
10.10.3 Home Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 HCV Antibody
11.6.2 HCV Viral Load
11.6.3 HCV Genotyping
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostic Centers
11.10.2 Hospitals
11.10.3 Home Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 HCV Antibody
12.6.2 HCV Viral Load
12.6.3 HCV Genotyping
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostic Centers
12.10.2 Hospitals
12.10.3 Home Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 HCV Antibody
13.6.2 HCV Viral Load
13.6.3 HCV Genotyping
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostic Centers
13.10.2 Hospitals
13.10.3 Home Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hepatitis C Virus (HCV) Antiviral Market: Competitive Dashboard
14.2 Global Hepatitis C Virus (HCV) Antiviral Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Abbott
14.3.3 Siemens
14.3.4 Qiagen
14.3.5 bioMérieux
14.3.6 Bio-Rad Laboratories
14.3.7 Meridian Bioscience
14.3.8 Vista Diagnostics
14.3.9 Biogate Laboratories
14.3.10 J.Mitra & Co. Ltd
14.3.11 Siemens Medical
14.3.12 General Biologicals
